Answers are grounded in this paper and cite their sources.
“I’m really surprised at how expensive health care is. But I knew it was expensive, having the background of nursing and stuff. But I didn’t realize how expensive it was until I was the actual patient.” The costs of cancer treatment have increased dramatically over the past decade and are projected to rise in future years (1,2). Patients and families are bearing more of the economic burden of high-cost cancer treatments from growing out-of-pocket costs and inadequate health insurance. As a result, the financial effects of cancer are increasingly recognized as an adverse event and important outcome for cancer survivors. Financial toxicity refers to negative effects on one’s finances directly from the cancer, whereas financial burden or hardship more generally refers to negative economic effects both from health-care costs and paying for basic needs (3). Financial hardship is linked to worse quality of life and earlier mortality in people with cancer (4,5). National studies suggest that more than one-third of cancer patients experience medical financial hardship (6-9). In this issue of the Journal, Lu et al. (10) report on findings regarding medical financial hardship from a national sample of adolescent and young adult (AYA) cancer survivors diagnosed between the ages of 15 and 39 years. The authors grouped medical financial hardship into 3 domains: material (ie, debt, out-of-pocket costs, problems paying for care), psychological (ie, distress and worry about current or future financial situation), and behavioral (ie, difficulty paying for care or cost-related treatment nonadherence). Compared with adults without a cancer history, AYA cancer survivors were more likely to experience material and behavioral financial hardship within the past 12 months, and many experienced all 3 domains of hardship. More than 75% of the sample was more than 6 years from diagnosis, a time when most survivors would be done with major cancer treatments such as surgery and chemotherapy. Their findings highlight how pernicious financial hardship and financial toxicity can be, particularly for AYA survivors. The financial health of AYA survivors may never recover after cancer diagnosis without appropriate clinical and policy intervention. AYA cancer occurs at a time of dramatic educational, economic, and social change (11). A cancer diagnosis during this time can leave an AYA cancer survivor and their family economically vulnerable. Many AYAs lack stable insurance coverage, tend to have health-care barriers such as a lack of primary care providers, and often have fewer assets that could affect their health care or protect them from medical costs going forward in cancer treatment (12-14). Addressing financial toxicity for AYA cancer survivors is a complex issue that requires solutions directed to patients and families, at hospitals and providers, and through national policy. Based on the results of Lu and colleagues (10), as well as this other research, we propose areas for future research in medical financial hardship and AYA cancer to identify actionable targets for clinical and policy intervention. This study found that differences in financial hardship between AYA survivors and people without a cancer history remained even after controlling for health insurance status (10). At the same time, in sensitivity analyses, results were similar between pre– and post–Affordable Care Act years. Even with expanded insurance options under the Affordable Care Act, many AYAs may be limited in insurance access because of the largely employer-based insurance system in the United States (15). For AYA survivors, interruptions to employment and educational attainment can be particularly challenging (16,17). This prevents AYA survivors from building up wealth that can protect them from future, postcancer financial hardship. Critical areas for future research include identifying whether gaps in work history and changes in educational attainment among AYAs lead to lower employment income after diagnosis and how this compounds over time. Additionally, AYAs experience a high burden of late and long-term effects of cancer treatment such as cardiovascular disease and persistent fatigue (18). AYA survivors may be limited in employment options to those with adequate health insurance to cover care of both cancer and late and long-term effects (19). Moreover, employment discrimination on the basis of disability is well documented (20), and although employers are required by law to provide reasonable accommodations for disabilities (21), requests are not always fulfilled. AYAs might be discriminated against in hiring, retention, or promotion due to their cancer or the effects on their work and educational history even though they can perform the job requirements. AYAs may need reasonable accommodations that are not fulfilled, preventing them from maintaining employment. Although this phenomenon is well documented outside of cancer, research is needed on the prevalence and long-term financial effects of disability discrimination in AYAs. Lu and colleagues (10) also highlight the importance of psychological financial burden and financial worry in addition to employment. Among both AYAs and the comparison sample, financial worry was more prevalent than material financial hardship. Exposure to health-care costs can increase financial worry (22), and financial worry can reduce adherence to medical recommendations (23-25) even when controlling for material hardship. Financial anxiety is also a distinct, separate aspect of financial hardship from material burden (26). More research is needed on this important aspect of financial hardship; clinical interventions are needed to address financial anxiety as well as material hardship. For AYAs, the development and testing of patient-level interventions require an in-depth understanding of the processes involved in financial burden. Although Lu et al. (10) provide context on how common financial burden is in AYAs, future research should expand our knowledge of important moderators and mediators such as precancer socioeconomic status as well as how financial issues affect quality of life, morbidity, and mortality outcomes. One proposed model for future research is the model of financial burden after cancer diagnosis (Figure 1), which elucidates the potential causal pathways and outcomes involved with financial burden and cancer (3). Identifying mediators and moderators will help tailor financial interventions to each individual patient. Theoretical model of financial burden. SES = socioeconomic status. Theoretical model of financial burden. SES = socioeconomic status. Lu and colleagues (10) present one study in a growing line that highlights the financial hardship as an outcome in cancer care, particularly for AYAs. We propose that future research focus on potential mechanisms that are amenable to policy interventions. Employment disruption and employment discrimination are key areas for AYAs. Another area for future research is how best to identify and address financial anxiety. Financial hardship remains a huge burden for AYAs, and clinicians and researchers should prioritize addressing these outcomes. “… Cancer can affect everyone no matter how much you’re rich or poor, and how expensive it is ridiculous and I have other cancer young adult cancer survivors like my boss and my friends, and they’re in debt because Medicaid either denied them for some reason, or it’s just really difficult – and you shouldn’t pay to breathe, in my opinion (Female cancer patient age 18-25 years at diagnosis from the Mountain West).” Not applicable. Role of the funder: Not applicable. Disclosures: The authors have no conflicts of interest to disclose. Author contributions: Conceptualization, writing—original draft, writing—review and editing: AK and SJ. Not applicable.
No takes yet. Share an insight, caveat, or question.
Kirchhoff et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: